89 related articles for article (PubMed ID: 10731721)
1. Development of a new inhibitor of glucosylceramide synthase.
Jimbo M; Yamagishi K; Yamaki T; Nunomura K; Kabayama K; Igarashi Y; Inokuchi JI
J Biochem; 2000 Mar; 127(3):485-91. PubMed ID: 10731721
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Modulation of Glycosphingolipid Metabolism.
Inokuchi JI; Ode T; Hara-Yokoyama M
Methods Mol Biol; 2018; 1804():401-410. PubMed ID: 29926420
[TBL] [Abstract][Full Text] [Related]
3. Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth.
Abe A; Radin NS; Shayman JA; Wotring LL; Zipkin RE; Sivakumar R; Ruggieri JM; Carson KG; Ganem B
J Lipid Res; 1995 Mar; 36(3):611-21. PubMed ID: 7775872
[TBL] [Abstract][Full Text] [Related]
4. Improved inhibitors of glucosylceramide synthase.
Lee L; Abe A; Shayman JA
J Biol Chem; 1999 May; 274(21):14662-9. PubMed ID: 10329660
[TBL] [Abstract][Full Text] [Related]
5. Glycosphingolipid depletion in fabry disease lymphoblasts with potent inhibitors of glucosylceramide synthase.
Abe A; Arend LJ; Lee L; Lingwood C; Brady RO; Shayman JA
Kidney Int; 2000 Feb; 57(2):446-54. PubMed ID: 10652021
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of glycosphingolipid biosynthesis by L-threo-1-phenyl-2-decanoylamino-1-propanol and its homologs in B16 melanoma cells.
Inokuchi J; Usuki S; Jimbo M
J Biochem; 1995 Apr; 117(4):766-73. PubMed ID: 7592537
[TBL] [Abstract][Full Text] [Related]
7. Glucosylceramide synthase inhibition enhances vincristine-induced cytotoxicity.
Olshefski RS; Ladisch S
Int J Cancer; 2001 Jul; 93(1):131-8. PubMed ID: 11391632
[TBL] [Abstract][Full Text] [Related]
8. Glucosylceramide synthase activity in murine epidermis: quantitation, localization, regulation, and requirement for barrier homeostasis.
Chujor CS; Feingold KR; Elias PM; Holleran WM
J Lipid Res; 1998 Feb; 39(2):277-85. PubMed ID: 9507988
[TBL] [Abstract][Full Text] [Related]
9. Effect of an inhibitor of glucosylceramide synthesis on cultured human keratinocytes.
Takami Y; Abe A; Matsuda T; Shayman JA; Radin NS; Walter RJ
J Dermatol; 1998 Feb; 25(2):73-7. PubMed ID: 9563272
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth.
Levery SB; Momany M; Lindsey R; Toledo MS; Shayman JA; Fuller M; Brooks K; Doong RL; Straus AH; Takahashi HK
FEBS Lett; 2002 Aug; 525(1-3):59-64. PubMed ID: 12163162
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of morpholino- and pyrrolidinosphingolipids as inhibitors of glucosylceramide synthase.
Miura T; Kajimoto T; Jimbo M; Yamagishi K; Inokuchi JC; Wong CH
Bioorg Med Chem; 1998 Sep; 6(9):1481-9. PubMed ID: 9801819
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glucosylceramide synthase stimulates autophagy flux in neurons.
Shen W; Henry AG; Paumier KL; Li L; Mou K; Dunlop J; Berger Z; Hirst WD
J Neurochem; 2014 Jun; 129(5):884-94. PubMed ID: 24494600
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol-dependent increases in glucosylceramide synthase activity in Niemann-Pick disease type C model cells: Abnormal trafficking of endogenously formed ceramide metabolites by inhibition of the enzyme.
Hashimoto N; Matsumoto I; Takahashi H; Ashikawa H; Nakamura H; Murayama T
Neuropharmacology; 2016 Nov; 110(Pt A):458-469. PubMed ID: 27539961
[TBL] [Abstract][Full Text] [Related]
14. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines.
Guan F; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2009 May; 106(18):7461-6. PubMed ID: 19380734
[TBL] [Abstract][Full Text] [Related]
15. Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells.
di Bartolomeo S; Spinedi A
Biochem Biophys Res Commun; 2001 Oct; 288(1):269-74. PubMed ID: 11594784
[TBL] [Abstract][Full Text] [Related]
16. A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus.
Zador IZ; Deshmukh GD; Kunkel R; Johnson K; Radin NS; Shayman JA
J Clin Invest; 1993 Mar; 91(3):797-803. PubMed ID: 8450061
[TBL] [Abstract][Full Text] [Related]
17. Glucosylceramide synthase inhibitors D-PDMP and D-EtDO-P4 decrease the GM3 ganglioside level, differ in their effects on insulin receptor autophosphorylation but increase Akt1 kinase phosphorylation in human hepatoma HepG2 cells.
Fedoryszak-Kuśka N; Panasiewicz M; Domek H; Pacuszka T
Acta Biochim Pol; 2016; 63(2):247-51. PubMed ID: 27172362
[TBL] [Abstract][Full Text] [Related]
18. Regulation of phospholipase C-gamma activity by glycosphingolipids.
Shu L; Lee L; Shayman JA
J Biol Chem; 2002 May; 277(21):18447-53. PubMed ID: 11886852
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of glucosylceramide synthase.
Shayman JA; Lee L; Abe A; Shu L
Methods Enzymol; 2000; 311():373-87. PubMed ID: 10563341
[No Abstract] [Full Text] [Related]
20. Synthesis, shedding, and intercellular transfer of human medulloblastoma gangliosides: abrogation by a new inhibitor of glucosylceramide synthase.
Olshefski R; Ladisch S
J Neurochem; 1998 Feb; 70(2):467-72. PubMed ID: 9453539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
